Controlled trial offers hope of restoring vision in LSCD patients

Trial’s controlled design was expected to quantify the original contribution of stem cells in the IMP. Credit: Petr Novák/Wikipedia.



  • Controlled trial offers hope for restoring vision in LSCD patients